Reply to: "Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices"

J Hepatol. 2023 Jul;79(1):e23-e24. doi: 10.1016/j.jhep.2023.02.025. Epub 2023 Feb 25.
No abstract available

Publication types

  • Meta-Analysis
  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carvedilol / therapeutic use
  • Esophageal and Gastric Varices* / etiology
  • Gastrointestinal Hemorrhage
  • Humans
  • Liver Cirrhosis / complications
  • Longitudinal Studies
  • Randomized Controlled Trials as Topic
  • Varicose Veins*

Substances

  • Carvedilol